Variant report
Variant | esv2752048 |
---|---|
Chromosome Location | chr4:44970482-45005872 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7679812 | chr4:44970482-44970483 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs554229056 | chr4:44970487-44970488 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188504961 | chr4:44970491-44970492 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559017193 | chr4:44970492-44970493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376263421 | chr4:44970504-44970505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527371005 | chr4:44970529-44970530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs137887155 | chr4:44970530-44970531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149448462 | chr4:44970541-44970542 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs532613005 | chr4:44970563-44970564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544858514 | chr4:44970606-44970607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs143963358 | chr4:44970613-44970614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556033195 | chr4:44970617-44970618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530099478 | chr4:44970629-44970630 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148631930 | chr4:44970648-44970649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566970563 | chr4:44970679-44970680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527740023 | chr4:44970688-44970689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571322428 | chr4:44970757-44970758 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73812456 | chr4:44970769-44970770 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571388940 | chr4:44970783-44970784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34325575 | chr4:44970801-44970802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185951694 | chr4:44970820-44970821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540938152 | chr4:44970830-44970831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs556817019 | chr4:44970835-44970836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568848162 | chr4:44970845-44970846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs535837077 | chr4:44970853-44970854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142183999 | chr4:44970854-44970855 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147402633 | chr4:44970860-44970861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139816784 | chr4:44970873-44970874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558389808 | chr4:44970936-44970937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577343891 | chr4:44970942-44970943 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs189576691 | chr4:44970943-44970944 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs145298828 | chr4:44970964-44970965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575256149 | chr4:44970970-44970971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528399695 | chr4:44971033-44971034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs147630815 | chr4:44971062-44971063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs141563913 | chr4:44971067-44971068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs552023942 | chr4:44971114-44971115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs374249556 | chr4:44971115-44971116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182040063 | chr4:44971116-44971117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs149976868 | chr4:44971135-44971136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs377093436 | chr4:44971150-44971151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10003399 | chr4:44971151-44971152 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs532320286 | chr4:44971189-44971190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550403037 | chr4:44971196-44971197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568809046 | chr4:44971197-44971198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs561423816 | chr4:44971223-44971224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs145273160 | chr4:44971229-44971230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372348586 | chr4:44971237-44971238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149161300 | chr4:44971238-44971239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs566434862 | chr4:44971245-44971246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:44968000-44975800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr4:44970200-44971000 | Enhancers | Fetal Heart | heart |
3 | chr4:44975800-44976600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr4:44984200-44984400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr4:44984200-44984400 | Enhancers | HMEC | breast |
6 | chr4:44984400-44984800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr4:44984400-44985200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr4:44984400-44985400 | Weak transcription | HMEC | breast |
9 | chr4:44985200-44986600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr4:44985200-44988600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr4:44985400-44988000 | Enhancers | HMEC | breast |
12 | chr4:44985800-44986400 | Enhancers | Fetal Stomach | stomach |
13 | chr4:44986600-44987800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr4:44987800-44988400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr4:44988600-44993400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
16 | chr4:44993400-44994000 | Strong transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr4:44994000-44997000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr4:44996800-44997400 | Enhancers | HMEC | breast |
19 | chr4:44997000-44998800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
20 | chr4:44998000-44998800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
21 | chr4:44998000-44998800 | Enhancers | Placenta Amnion | Placenta Amnion |
22 | chr4:44998800-45006200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
23 | chr4:45000600-45000800 | Enhancers | Placenta Amnion | Placenta Amnion |